Alumis to participate in September investor conferences
Alumis Inc. (ALMS) announced it will participate in upcoming September investor conferences.
SOUTH SAN FRANCISCO, Calif., Sept.
04, 2026 (GLOBE NEWSWIRE) -- Alumis Inc.
NASDAQ:ALMS, a late-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor confe…